1995
DOI: 10.1159/000150429
|View full text |Cite
|
Sign up to set email alerts
|

Human Papillomavirus DNA in Genital Cancers, Metastases, and Lymph Nodes

Abstract: To evaluate the utility of human papillomavirus (HPV) DNA as molecular marker for diagnostic screening of lymph nodes for cancer metastases, we examined 16 involved and 124 histologically cancer-free nodes of 34 patients with cervical, vulval, or vaginal carcinomas associated with HPV 6, 16, 18, 31, 33, 45, or X. All metastases of HPV-positive tumors contained viral DNA of the same type as the primary cancer but in one case the copy number of viral genomes was dramatically reduced. In a varying proportion of h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

1996
1996
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 23 publications
0
9
0
Order By: Relevance
“…Insofar as the PCRs used were sensitive [Cavuslu et al, 1996], detection of HPV-negative metastases from patients with HPV-positive tumours was surprising, though again this has been noted by others [Fuchs et al, 1989;Yanuck et al, 1991;Crook et al, 1992;Mvula et al, 1994]. The explanations for such cases are unknown but might include genetic heterogeneity or biclonal origin of metastatic tumour cells [Beyer-Finkler et al, 1995]. We also found HPV DNA in uninvolved (10) DO-1 This study a BCLL, B-cell chronic lymphocytic leukemia; NHL, HIV-1-associated non-Hodgkin's lymphoma; Ca, carcinoma; LN1, patients with metastatic or, LN2, uninvolved lymph nodes draining from a primary cervical carcinoma; CIN, cervical intraepithelial neoplasia; Ab, antibody used for detection of p53 overexpression.…”
Section: Discussionmentioning
confidence: 92%
“…Insofar as the PCRs used were sensitive [Cavuslu et al, 1996], detection of HPV-negative metastases from patients with HPV-positive tumours was surprising, though again this has been noted by others [Fuchs et al, 1989;Yanuck et al, 1991;Crook et al, 1992;Mvula et al, 1994]. The explanations for such cases are unknown but might include genetic heterogeneity or biclonal origin of metastatic tumour cells [Beyer-Finkler et al, 1995]. We also found HPV DNA in uninvolved (10) DO-1 This study a BCLL, B-cell chronic lymphocytic leukemia; NHL, HIV-1-associated non-Hodgkin's lymphoma; Ca, carcinoma; LN1, patients with metastatic or, LN2, uninvolved lymph nodes draining from a primary cervical carcinoma; CIN, cervical intraepithelial neoplasia; Ab, antibody used for detection of p53 overexpression.…”
Section: Discussionmentioning
confidence: 92%
“…These results are in keeping with those of Füle et al [21], showing the lack of any close correlation between metastasis and viral detection in lymph nodes. Beyer-Finkler et al [29] pointed out that lymph node HPV DNA might originate from disintegrating tumor cells, being conveyed passively by lymphatic flow or actively by phagocytic cells. Füle et al showed that, in highly heterogeneous advanced-stage tumors with numerous genetic original article Annals of Oncology aberrations, the loss of HPV DNA did not affect the proliferative capacity of cell clones [21].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, even non-enlarged, non-metastatic cancer sometimes has a worse outcome despite a low clinical stage disease. Some studies have examined the prognostic value of HPV DNA detection in histological free PLN but so far a consensus has not been reached [Beyer-Finkler et al, 1995;Garzetti et al, 1998;Chan et al, 2005]. This study had two goals both to asses the prevalence and location of HPV types in tumors and lymph nodes and analyze the influence of H-ras mutations on the clinical course of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…The role of HPV in the development of lymph node metastasis and adverse clinical outcome is poorly understood. Little is known about the intrinsic mechanisms involved in the metastatic process in HPV positive carcinoma, and it was suggested that HPV DNA in lymph nodes may indicate an early, subclinical metastasis [Beyer-Finkler et al, 1995;Garzetti et al, 1998;Chan et al, 2005].…”
Section: Introductionmentioning
confidence: 99%